People in the News | GenomeWeb

People in the News


Synthetic Genomics Vaccines, which focuses on developing vaccines using sequencing and synthetic genomic technologies, has appointed Sammy Farah as president.

Farah joins the company from Immune Design, where he was chief business officer. Previously, he was at Versant Ventures, where he specialized in biotechnology investing; and at Merck, where he led technology support for multiple commercial vaccines.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.